BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11792768)

  • 21. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials.
    Almalki MH; Altuwaijri MA; Almehthel MS; Sirrs SM; Singh RS
    Clin Invest Med; 2012 Jun; 35(3):E132-43. PubMed ID: 22673316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of blood glucose in diabetic dialysis patients].
    Hori K; Fujimi S
    Nihon Rinsho; 1992 Jan; 50 Suppl():192-6. PubMed ID: 1578677
    [No Abstract]   [Full Text] [Related]  

  • 23. Profound hypokalemia in continuous ambulatory peritoneal dialysis.
    Rostand SG
    Arch Intern Med; 1983 Feb; 143(2):377-8. PubMed ID: 6824407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the uptake of human and porcine insulins given intraperitoneally to patients with diabetes mellitus on continuous ambulatory peritoneal dialysis.
    Webb DB; Banks RA; Browning MJ; Luzio SD; Winning RC
    Diabetes Res; 1986 Feb; 3(2):103-6. PubMed ID: 3516521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and biological effect of intraperitoneal insulin administration in patients with terminal renal failure treated by continuous ambulatory peritoneal dialysis (CAPD).
    Peetoom JJ; Willekens FL; Meinders AE
    Neth J Med; 1985; 28(10):435-41. PubMed ID: 3908952
    [No Abstract]   [Full Text] [Related]  

  • 26. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous ambulatory peritoneal dialysis in terminal renal-insufficiency diabetics].
    Kuhlmann H; Thomae U; Herrmann M; Eberhard K
    Med Klin; 1981 Mar; 76(6):169-76. PubMed ID: 7015094
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specific aspects of peritoneal dialysis in diabetic patients].
    Opatrná S; Klaboch J
    Vnitr Lek; 2008 May; 54(5):523-9. PubMed ID: 18630640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal insulin and the malignant omentum syndrome.
    Harrison NA; Rainford DJ
    Nephrol Dial Transplant; 1988; 3(1):103. PubMed ID: 3132630
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of transperitoneal insulin transport.
    Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
    Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic kidney failure in diabetics with peritoneal dialysis].
    Bednárová V; Sulková S
    Cas Lek Cesk; 1996 May; 135(11):340-3. PubMed ID: 8706069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advantages of continuous ambulatory peritoneal dialysis to the diabetic with renal failure.
    Flynn CT; Hibbard J; Dohrman B
    Proc Eur Dial Transplant Assoc; 1979; 16():184-93. PubMed ID: 548979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
    Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraperitoneal (125I) insulin absorption during intermittent and continuous peritoneal dialysis.
    Wideröe TE; Smeby LC; Berg KJ; Jörstad S; Svartås TM
    Kidney Int; 1983 Jan; 23(1):22-8. PubMed ID: 6339786
    [No Abstract]   [Full Text] [Related]  

  • 38. [Continuous ambulatory peritoneal dialysis].
    Risler T; Passlik J; Grabensee B
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1659-60. PubMed ID: 7140542
    [No Abstract]   [Full Text] [Related]  

  • 39. Dialysis considerations for diabetic patients.
    Khanna R
    Kidney Int Suppl; 1993 Feb; 40():S58-64. PubMed ID: 8445840
    [No Abstract]   [Full Text] [Related]  

  • 40. [Which dialysis method should be proposed to type 2 diabetics?].
    Ryckelynck JP
    Nephrologie; 2000; 21(4):161-2. PubMed ID: 10976430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.